Slingshot News

Slingshot’s inventory management module now records and distributes drug pedigree information in compliance with the Drug Supply Chain Security Acts (DSCSA).  A Transaction statement with the seven required DSCSA assertions and Transaction history Information documenting changes in ownership is captured for each lot received.  The review and acceptance of pedigree information is required before finalizing a receipt. 
For outbound shipments, a Transaction Statement is “e-signed” as part of the shipment confirmation process.  This statement and associated transaction histories are forwarded with the shipping documentation (electronic and/or paper). 

Facilities are shortening the time required to record supplier invoices.  The accuracy of the OCR process varies widely.  Each supplier has its own terminology and document layout making the process especially challenging.  Slingshot’s Intelligent OCR process “learns” the supplier’s layout improving accuracy as invoices are processed.  If the layout changes, “Intelligent OCR” automatically detects the change and adjusts its rules for the supplier.

Slingshot has added “Intelligent OCR” to its invoice capture and matching facilities.  These facilities are available in release G2-12 of Slingshot’s purchasing and accounts payable applications scheduled for...